REQUEST A DEMO
Total
USD $0.00
Search more companies

Caspian Tamin Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Caspian Tamin Pharmaceutical Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Caspian Tamin is a pharmaceutical company, affiliate of the Tamin Pharmaceutical Investment Co. (TPICO). It is headquartered in Tehran and its manufacturing plant is located in Guilan, northern Iranian. The company produces volume parenteral dosage forms, including mainly ampoules, in addition to semisolids (cream, ointment, gel, and suppository), oral liquids and syrups. Its product range includes 89 pharmaceutical products. Caspian Tamin exports to Afghanistan, Iraq, Uzbekistan, Ukraine, Uganda, Tajikistan, Yemen, Jordan, Vietnam, Pakistan, Kenya, and Guinea.

Legal Address
Dr. Fatemi Sq, No.1, Beastoon Ave, Darugostar Building
Tehran; Tehran;

Contact Details: Purchase the Caspian Tamin Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.caspiantamin.com

Basic Information
Total Employees:
Purchase the Caspian Tamin Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Caspian Tamin Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Caspian Tamin Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1983
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
0.7%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Caspian Tamin Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
39.4%
Total operating revenue
39.64%
Operating profit (EBIT)
45.05%
EBITDA
46.48%
Net Profit (Loss) for the Period
45.64%
Total assets
31.27%
Total equity
31.12%
Operating Profit Margin (ROS)
1.73%
Net Profit Margin
1.15%
Return on Equity (ROE)
6.43%
Debt to Equity Ratio
-16.23%
Quick Ratio
-0.08%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?